271 related articles for article (PubMed ID: 32921794)
21. Hyperactivity of caudate, parahippocampal, and prefrontal regions during working memory in never-medicated persons at clinical high-risk for psychosis.
Thermenos HW; Juelich RJ; DiChiara SR; Mesholam-Gately RI; Woodberry KA; Wojcik J; Makris N; Keshavan MS; Whitfield-Gabrieli S; Woo TU; Petryshen TL; Goldstein JM; Shenton ME; McCarley RW; Seidman LJ
Schizophr Res; 2016 May; 173(1-2):1-12. PubMed ID: 26965745
[TBL] [Abstract][Full Text] [Related]
22. Increased Striatal and Reduced Prefrontal Cerebral Blood Flow in Clinical High Risk for Psychosis.
Kindler J; Schultze-Lutter F; Hauf M; Dierks T; Federspiel A; Walther S; Schimmelmann BG; Hubl D
Schizophr Bull; 2018 Jan; 44(1):182-192. PubMed ID: 28575528
[TBL] [Abstract][Full Text] [Related]
23. Dynamic functional connectivity impairments in early schizophrenia and clinical high-risk for psychosis.
Du Y; Fryer SL; Fu Z; Lin D; Sui J; Chen J; Damaraju E; Mennigen E; Stuart B; Loewy RL; Mathalon DH; Calhoun VD
Neuroimage; 2018 Oct; 180(Pt B):632-645. PubMed ID: 29038030
[TBL] [Abstract][Full Text] [Related]
24. Acute oxytocin effects in inferring others' beliefs and social emotions in people at clinical high risk for psychosis.
Schmidt A; Davies C; Paloyelis Y; Meyer N; De Micheli A; Ramella-Cravaro V; Provenzani U; Aoki Y; Rutigliano G; Cappucciati M; Oliver D; Murguia S; Zelaya F; Allen P; Shergill S; Morrison P; Williams S; Taylor D; Borgwardt S; Yamasue H; McGuire P; Fusar-Poli P
Transl Psychiatry; 2020 Jun; 10(1):203. PubMed ID: 32572020
[TBL] [Abstract][Full Text] [Related]
25. The impact of cannabidiol treatment on resting state functional connectivity, prefrontal metabolite levels and reward processing in recent-onset patients with a psychotic disorder.
van Boxel R; Gangadin SS; Janssen H; van der Steur S; van der Vinne LJC; Dortants L; Pelgrim TAD; Draisma LWR; Tuura R; van der Meer P; Batalla A; Bossong MG
J Psychiatr Res; 2023 Jul; 163():93-101. PubMed ID: 37207437
[TBL] [Abstract][Full Text] [Related]
26. Exploring neural dysfunction in 'clinical high risk' for psychosis: a quantitative review of fMRI studies.
Dutt A; Tseng HH; Fonville L; Drakesmith M; Su L; Evans J; Zammit S; Jones D; Lewis G; David AS
J Psychiatr Res; 2015 Feb; 61():122-34. PubMed ID: 25479766
[TBL] [Abstract][Full Text] [Related]
27. Probabilistic Category Learning and Striatal Functional Activation in Psychosis Risk.
Karcher NR; Hua JPY; Kerns JG
Schizophr Bull; 2019 Mar; 45(2):396-404. PubMed ID: 29590478
[TBL] [Abstract][Full Text] [Related]
28. Striatum-related functional activation during reward- versus punishment-based learning in psychosis risk.
Karcher NR; Hua JPY; Kerns JG
Neuropsychopharmacology; 2019 Oct; 44(11):1967-1974. PubMed ID: 31272104
[TBL] [Abstract][Full Text] [Related]
29. Effects of cannabidiol (CBD) on regional cerebral blood flow.
Crippa JA; Zuardi AW; Garrido GE; Wichert-Ana L; Guarnieri R; Ferrari L; Azevedo-Marques PM; Hallak JE; McGuire PK; Filho Busatto G
Neuropsychopharmacology; 2004 Feb; 29(2):417-26. PubMed ID: 14583744
[TBL] [Abstract][Full Text] [Related]
30. fMRI study of cannabidiol-induced changes in attention control in treatment-resistant epilepsy.
Allendorfer JB; Nenert R; Bebin EM; Gaston TE; Grayson LE; Hernando KA; Houston JT; Hansen B; Szaflarski JP
Epilepsy Behav; 2019 Jul; 96():114-121. PubMed ID: 31129526
[TBL] [Abstract][Full Text] [Related]
31. Learning to trust: social feedback normalizes trust behavior in first-episode psychosis and clinical high risk.
Lemmers-Jansen ILJ; Fett AJ; Hanssen E; Veltman DJ; Krabbendam L
Psychol Med; 2019 Apr; 49(5):780-790. PubMed ID: 29897026
[TBL] [Abstract][Full Text] [Related]
32. A single dose of mirtazapine modulates neural responses to emotional faces in healthy people.
Rawlings NB; Norbury R; Cowen PJ; Harmer CJ
Psychopharmacology (Berl); 2010 Dec; 212(4):625-34. PubMed ID: 20809213
[TBL] [Abstract][Full Text] [Related]
33. Longitudinal Assessment and Functional Neuroimaging of Movement Variability Reveal Novel Insights Into Motor Dysfunction in Clinical High Risk for Psychosis.
Dean DJ; Bernard JA; Damme KSF; O'Reilly R; Orr JM; Mittal VA
Schizophr Bull; 2020 Dec; 46(6):1567-1576. PubMed ID: 32662507
[TBL] [Abstract][Full Text] [Related]
34. Neural basis of Delta-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition.
Borgwardt SJ; Allen P; Bhattacharyya S; Fusar-Poli P; Crippa JA; Seal ML; Fraccaro V; Atakan Z; Martin-Santos R; O'Carroll C; Rubia K; McGuire PK
Biol Psychiatry; 2008 Dec; 64(11):966-73. PubMed ID: 18589404
[TBL] [Abstract][Full Text] [Related]
35. Lesion side matters - an fMRI study on the association between neural correlates of watching dynamic fearful faces and their evaluation in patients with temporal lobe epilepsy.
Labudda K; Mertens M; Steinkroeger C; Bien CG; Woermann FG
Epilepsy Behav; 2014 Feb; 31():321-8. PubMed ID: 24210457
[TBL] [Abstract][Full Text] [Related]
36. Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users.
Hindocha C; Freeman TP; Schafer G; Gardener C; Das RK; Morgan CJ; Curran HV
Eur Neuropsychopharmacol; 2015 Mar; 25(3):325-34. PubMed ID: 25534187
[TBL] [Abstract][Full Text] [Related]
37. The interaction of working memory and emotion in persons clinically at risk for psychosis: an fMRI pilot study.
Pauly K; Seiferth NY; Kellermann T; Ruhrmann S; Daumann B; Backes V; Klosterkötter J; Shah NJ; Schneider F; Kircher TT; Habel U
Schizophr Res; 2010 Jul; 120(1-3):167-76. PubMed ID: 20053536
[TBL] [Abstract][Full Text] [Related]
38. The Impact of Cannabidiol on Human Brain Function: A Systematic Review.
Batalla A; Bos J; Postma A; Bossong MG
Front Pharmacol; 2020; 11():618184. PubMed ID: 33551817
[No Abstract] [Full Text] [Related]
39. Cannabidiol modulation of hippocampal glutamate in early psychosis.
O'Neill A; Annibale L; Blest-Hopley G; Wilson R; Giampietro V; Bhattacharyya S
J Psychopharmacol; 2021 Jul; 35(7):814-822. PubMed ID: 33860709
[TBL] [Abstract][Full Text] [Related]
40. Cannabinoid modulation of functional connectivity within regions processing attentional salience.
Bhattacharyya S; Falkenberg I; Martin-Santos R; Atakan Z; Crippa JA; Giampietro V; Brammer M; McGuire P
Neuropsychopharmacology; 2015 May; 40(6):1343-52. PubMed ID: 25249057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
